Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database

Hypoglycemia is a known risk with all beta-blockers (BB). Little is known about BB-associated hypoglycemia in pediatric patients in the post-market setting.

This poster describes pediatric hypoglycemia cases associated with BB in the FDA Adverse Event Reporting System (FAERS), National Poison Data System (NPDS), and medical literature and characterizes this adverse event in the population-based Sentinel Distributed Database (SDD). It was presented at the 2024 ISPE Annual Meeting.